
The National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria has issued a stern warning to patent medicine dealers, urging them to cease the sale of substandard and counterfeit drugs.
This call was made during a one-day sensitisation and awareness campaign held in Abuja on September 30.
NAFDAC's Director-General, Prof. Mojisola Adeyeye, highlighted the severe risks associated with these inferior drugs, describing them as "poisonous and hazardous to human health." Represented by Bitrus Fraden, Director of Post Marketing Surveillance, Adeyeye emphasized the importance of providing genuine products and high-quality services to the public. She cautioned against any malpractice driven by financial gain, stating, “Do not engage in any sharp practices just because you are driven by money; the welfare of the people should be the driving force.”
Adeyeye also urged medicine dealers to source their products from reputable suppliers to ensure they meet the required standards. “With positive thinking, we will serve Nigerians with products that are better by first scrutinising everything before putting them on our shelves for sale,” she added.
Odoh-Theophilus Okwudili, Chairman of the Nigeria Association of Patent and Proprietary Medicine Dealers (NAPPMED), commended NAFDAC for its effective regulation and monitoring of pharmaceutical products. He noted that the agency’s sensitisation programme is crucial for ensuring the safety and quality of medicines, reducing the circulation of counterfeit drugs, and improving access to genuine products. Okwudili called on other stakeholders in drug and standard regulations to collaborate with NAFDAC, emphasizing the need for guidance and support for patent medicine dealers.
コメント